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The plasma membrane and all membrane-bound
organelles except for the Golgi and endoplasmic
reticulum (ER) are equipped with pattern-recognition
molecules to sense microbes or their products and
induce innate immunity for host defense. Here, we
report that inositol-requiring-1a (IRE1a), an ER pro-
tein that signals in the unfolded protein response
(UPR), is activated to induce inflammation by binding
a portion of cholera toxin as it co-opts the ER to
cause disease. Other known UPR transducers,
including the IRE1a-dependent transcription factor
XBP1, are dispensable for this signaling. The inflam-
matory response depends instead on the RNase
activity of IRE1a to degrade endogenous mRNA, a
process termed regulated IRE1a-dependent decay
(RIDD) of mRNA. The mRNA fragments produced
engage retinoic-acid inducible gene 1 (RIG-I), a cyto-
solic sensor of RNA viruses, to activate NF-kB and
interferon pathways. We propose IRE1a provides
for a generalized mechanism of innate immune sur-
veillance originating within the ER lumen.
INTRODUCTION
Mammalian cells have evolved diverse mechanisms of innate
immunity to detect microbes in the extracellular space and
upon invasion. Most involve pattern-recognition receptors
(PRRs) that sense common pathogen-associated molecular pat-
terns (PAMPs) defining broad classes of microbes. The PRRs
include members of the Toll-like receptor (TLR), NOD-like recep-
tor, and retinoic-acid inducible gene 1 (RIG-I)-like receptor fam-
ilies of proteins that survey various subcellular compartments for
the presence of microbes and their associated products (Barton558 Cell Host & Microbe 13, 558–569, May 15, 2013 ª2013 Elsevier Iand Kagan, 2009). To date, PRRs have been found to survey the
extracellular environment, the cytosol, various endosomes,
mitochondria, and peroxisomes, and recently the nucleus
(Li et al., 2012). With this diversity of potential sites for innate
immune surveillance, it is surprising that two of the largest
cellular organelles, the Golgi complex and endoplasmic reticu-
lum (ER), have no known innate recognition system, even though
some viruses and bacterial toxins traffic through these organ-
elles en route to the cytosol.
Cholera toxin (CT) is the major virulence determinant of Vibrio
cholera,and the prototypical member of a family of AB5 subunit
bacterial toxins that traverses the Golgi and ER to gain access
to the cytosol (Sandvig et al., 1992). In the ER, a fragment of
the CT A subunit, termed the A1 chain, unfolds and dissociates
from the B subunit and retrotranslocates across the ER mem-
brane, a process that exploits the machinery for ER-associated
degradation (ERAD) of terminally misfolded proteins (Tsai et al.,
2001). Once in the cytosol, the A1 chain refolds to become an
ADP ribosyl transferase that causes disease.
Here, we used CT to reveal a potent role for the ER in innate
host defense against extracellular microbes. The mechanism in-
volves inositol-requiring-1a (IRE1a), one of three ER membrane
proteins in metazoans that sense terminally misfolded proteins
to induce the UPR (Ron and Walter, 2007). The canonical UPR,
however, is dispensable for signaling in this pathway. Rather,
the A1 chain selectively activates IRE1a to cleave endogenous
messenger RNA (mRNA) into fragments that engage RIG-I, a
key pattern recognition receptor for invading viruses. Activation
of RIG-I leads to a NF-kB-dependent inflammatory response.
We propose that IRE1a acts as the sensor for a generalized
mechanism of innate immune surveillance that originates from
within the ER lumen.
RESULTS
Rapid Innate Immune Signaling Response to CT In Vivo
To test whether host cells can innately sense CT upon entry into
the ER, we prepared mutant toxins lacking catalytic activitync.
Table 1. Toxin-Induced Inflammatory Response in Mouse and Human Intestinal Epithelial Cells
mRNA Expression (Fold Change over Untreated Controls)
Mouse Intestine:
Whole Tissue (2 hr)
Mouse Intestine:
IECs (2 hr)
Cultured Human Intestinal
T84 Cells (4 hr)
Gene Symbol E/E CTB E/E CTB E/E CTB
IL8/CXCL1 2.00 1.02 4.59 1.01 5.24 1.66
IL1B 1.41 1.13 2.70 0.88 5.09 1.81
TNFA NC NC 1.45 0.53 4.17 1.44
CCL20 2.40 0.61 NC NC 2.50 1.69
IFNB1 1.42 1.33 NC NC 1.71 1.09
NFKBIA ND ND ND ND 1.64 1.18
E/E, E110D/E112D enzymatically inert CT; CTB, B subunit only; IECs, intestinal epithelial cells; NC, no change detected; ND, not determined.Mean fold
change is reported, n = 3 independent experiments; in all cases, a two-tailed t test between E/E and CTB is p < 0.05.
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IRE1a Operates in Innate Immunity within the ER(termed E/E [Jobling and Holmes, 2001]) or unable to retrotrans-
locate (termed R192G [Tsai et al., 2001]) (Figures S1A–S1C avail-
able online). We also prepared a B subunit only toxin lacking the
A subunit entirely (termed CTB). Each of these mutants was
nontoxic when applied to human intestinal T84 cells in mono-
layer culture. None contained detectable amounts of bacterial
lipopolysaccharide (LPS) as measured in mouse macrophages.
The enzymatically inactive E/E mutant and CTB toxins were
administered by gastric gavage into BALB/c mice. Whole-tissue
preparations of proximal intestine and isolated jejunal epithelial
cells were analyzed for transcription of inflammatory genes by
multiplexed direct quantification of individual mRNAs. Within
2 hr of toxin application, the enzymatically inactive E/E mutant,
but not CTB, induced transcription of multiple inflammatory cy-
tokines (Table 1). A similar inflammatory response was obtained
when the toxins were applied to apical surfaces of human intes-
tinal T84 cells in monolayer culture (Table 1). Thus, intestinal cells
detect the enzymatically inert CT mutant E/E and respond by
transcription of inflammatory genes, suggesting a form of innate
immunity. CTB, lacking the A subunit entirely, was not active.
Since only the A subunit co-opts ERAD to enter the cytosol,
the result suggests that the inflammatory signal originates from
inside the ER as it processes the A subunit for retrotranslocation
or upon entry of the A1 chain into the cytosol.
The CT A Subunit Is Sensed upon ER Entry and Induces
NF-kB-Dependent Responses
To determine how the A subunit induces the inflammatory
response, we exposed the polarized human intestinal cell lines
T84 and Caco-2 to the wild-type and mutant toxins, including
the A subunit mutant that is strongly inhibited in retrotransloca-
tion and essentially nontoxic (R192G [Saslowsky et al., 2010;
Tsai et al., 2001; Wernick et al., 2010]). The inflammatory
response was measured 4 hr later by real-time quantitative
PCR (qPCR) for transcription of the cytokines interleukin-8
(IL-8) and IL-6 (Figures 1A and 1B) and by protein expression
(Figure S1E). Only toxins containing the A subunit induced the
inflammatory cytokines as observed in the mouse intestine.
CTB was inactive. Higher concentrations of toxin induced 5- to
6-fold higher signals, implicating a dose effect (Figure S1F).
Toxin entry into the ER was required, because blockade of retro-
grade vesicular transport from plasmamembrane to ER by treat-
ment with brefeldin A (BFA) (Fujinaga et al., 2003) completelyCell Hinhibited signal transduction (Figure 1C). In this time frame,
BFA had no detectable effect on signaling by basolaterally
applied LPS (bLPS), showing that the BFA effect was specific
for the cellular response to CT. The R192G mutant was active
in both intestinal cell lines, indicating that the inflammatory signal
originates from the ER lumen. Thus, intestinal epithelial cells
sense the CT A subunit upon entry into the ER and induce inflam-
matory mediators.
Because the CT A subunit is unfolded by ER chaperones
before retrotranslocation, we considered whether this might
elicit the unfolded protein response (UPR) as suggested before
(Dixit et al., 2008). This was evidenced by increased expression
of the ER chaperone BiP 16 hr after intoxication (Figures S2A and
S2B). The UPR has been linked to inflammatory signals via the
Jun N-terminal kinase (JNK) and NF-kB pathways (Pahl et al.,
1996; Urano et al., 2000). We found no evidence for activation
of the JNK pathway (Figures S2C–S2F), but the NF-kB complex
was activated. This was evidenced by immunoblot detection of
the NF-kB p65 subunit in nuclear extracts of CT-treated (but
not control) cells (Figure 2A). CTB did not cause nuclear translo-
cation of p65, consistent with its lack of activity in the gene
expression assays. Furthermore, immunoblot of total cell lysates
for phospho-IKKa/b and phospho-IkBa showed that these up-
stream components of the NF-kB pathway were also activated
by the holotoxins (A and B subunits assembled together), but
not by CTB (Figure 2B). Finally, Bay11, a small-molecule inhibitor
of IkBa activation, completely blocked the holotoxin-induced
inflammatory cytokine response (Figure 2C). Thus, inflammatory
signal transduction by the CT A subunit in the ER is NF-kB
dependent.
TheCTASubunit Activates IRE1a, but Not theCanonical
UPR
In metazoans, three transmembrane ER proteins are known to
activate cytosolic responses to unfolded proteins in the ER
lumen: IRE1a, PKR-like ER kinase (PERK), and activating tran-
scription factor-6 (ATF6) (Ron and Walter, 2007). We found no
evidence for activation of PERK or ATF6 (Figures S3A–S3E),
but IRE1a was activated (Figures 3A–3C). This was assayed in
total cell extracts by immunoblot for phosphorylated and non-
phosphorylated forms of IRE1a using phos-tag SDS-PAGE.
We found phospho-IRE1a in cells treated with all the holotoxins
at 16 hr and at earlier times after intoxication with WT CT and theost & Microbe 13, 558–569, May 15, 2013 ª2013 Elsevier Inc. 559
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Figure 1. The CT A Subunit Induces IL-6 and IL-8 from within the ER
(A) Polarized T84 cells were intoxicated with 3 nM toxin for 4 hr, and IL-6 and IL-8 were assessed by real-time qPCR. The TLR4 agonist LPS (applied basolaterally,
bLPS) and the ER stress-inducing agent thapsigargin (Thap) were used as positive controls.
(B) Polarized Caco-2 cells treated as in (A).
(C) Polarized T84 cells treated as in (A) with or without brefeldin A (BFA) pretreatment and assayed for IL-6 by real-time qPCR.
Open bars represent negative controls. Gray bars represent positive controls. wt CT, wild-type CT; E/E, E110D/E112D mutant; R192G, R192G mutant; CTB,
B subunit alone. Data are shown as means ± SEM. *p < 0.05 by ANOVA. See also Figure S1.
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IRE1a Operates in Innate Immunity within the ERR192G mutant (Figure 3A, slower migrating band). CTB did not
induce phosphorylation of IRE1a at any time. Activation of
IRE1a by the holotoxins was confirmed by real-time qPCR for
the spliced RNAmessage of the transcription factor XBP1, which
is cleaved to its active form by IRE1a upon activation (Ron and
Walter, 2007). Spliced XBP1 was apparent starting 1 hr after
intoxication and increased in abundance over time (Figure 3B).
CTB was again completely inactive. XBP1 splicing induced by
the R192G mutant, however, was not detected until 16 hr after
intoxication, suggesting that XBP1 may not be required for the
cytokine response. The delay in XBP1 splicing is perhaps
explained by incomplete unfolding of themutant R192GA1 chain
within the ER lumen (Tsai et al., 2001). We also assayed for a
downstream product of the IRE1a/XBP1 pathway, the ER chap-
erone ERdj4. All the holotoxins (but not CTB) induced transcrip-
tion of ERdj4 by 16 hr after intoxication (Figure 3C). Thus, IRE1a
was activated by the A subunit shortly after toxin entry into the
ER, but PERK and ATF6 were not detectably activated.
To confirm the specificity for IRE1a in originating the inflam-
matory cytokine response, we first silenced expression of
IRE1a and XBP1 in HeLa cells by stable transfection with short
hairpin RNA (shRNA) against either IRE1a or XBP1. Strong
depletion (>90%) of these proteins was shown by immunoblot
(Figures 3D0 and 3E0). The cytokine response induced by the A
subunit was assessed as described above (Figure 1). As ex-
pected, all the holotoxins caused expression of the inflammatory
cytokines IL-6 and IL-8 in HeLa cells transfected with control
shRNA against red fluorescent protein (shRFP), and there was
no response to CTB (Figure 3D, left columns, and data not
shown). However, in HeLa cells depleted of IRE1a, none of the
toxins induced inflammatory cytokines (Figure 3D, right col-
umns, shIRE1a) or nuclear translocation of p65 (Figure 3F, four
lanes on left). IRE1a depletion did not interfere with intracellular
trafficking of the toxins from the cell surface through the ER to
the cytosol (Figure S3F), arguing against indirect effects on toxin
signaling.560 Cell Host & Microbe 13, 558–569, May 15, 2013 ª2013 Elsevier IXBP1 is a major effector of IRE1a signaling and contributes to
cytokine gene expression in LPS-stimulated macrophages
(Martinon et al., 2010). In HeLa cells, however, although gene
silencing of XBP1 enhanced the baseline expression of IL-6
and IL-8 (as observed before [Kaser et al., 2008]), this had no
effect on toxin-mediated induction of the inflammatory cytokines
(Figure 3E) or nuclear translocation of p65 (Figure 3F, four lanes
to right).
The same results were obtained in independent studies using
mouse embryonic fibroblasts (MEFs) prepared from animals
completely lacking either IRE1a or XBP1 (IRE1a/ or XBP1/)
(Figures 3G and 3H). As for XBP-1, MEFs lacking PERK also
responded normally to intoxication by all the holotoxins (Fig-
ure 3I). The B subunit was inactive in all cases.
Thus, IRE1a is required for the inflammatory cytokine
response induced by the CT A subunit. This is initiated by entry
of the A subunit into the ER without requirement for enzymatic
activity or for retrotranslocation of the A1 chain to the cytosol.
XBP1, PERK, and ATF6, however, are dispensable, findings
that define an unconventional activation of UPR modules for
signal transduction initiated by the CT A subunit.
Regulated IRE1-Dependent Decay and RIG-I Transduce
the Toxin-Recognition Signal from IRE-1a to NF-kB
How then does IRE1a signal to NF-kB after its activation by the A
subunit in the ER lumen? IRE1a can also act as a promiscuous
endonuclease degrading a subset of mRNA associated with
the ER membrane (a process termed regulated IRE1-dependent
decay, or RIDD (Hollien et al., 2009; Hollien and Weissman,
2006). To test RIDDs contribution to A subunit induction of in-
flammatory cytokines, we used a small-molecule selective inhib-
itor of IRE1a RNase activity, 4m8C. 4m8C does not block the
kinase activity of IRE1a, nor does it affect the endonuclease
activity of IRE1a-related RNase L or other elements of the UPR
signaling cascades, but it efficiently interferes with RIDD and
XBP1 splicing (Cross et al., 2012). Pretreatment with 4m8Cnc.
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Figure 2. The Inflammatory Response
Induced by CT A Subunit Is NF-kB
Dependent
(A and B) Lysates of T84 cells were analyzed for
nuclear translocation of p65 by immunoblot (A)
and for phosphorylation of IKKa and IkBa (B).
TATA-binding protein (TBP), total IKKa/b, and total
IkBa are loading controls.
(C) T84 cells pretreated with NF-kB inhibitor Bay11
were intoxicated and analyzed for IL-8 by real-
time PCR.
Data are shown asmeans ± SEM. Nomenclature is
as described in Figure 1. See also Figure S2.
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IRE1a Operates in Innate Immunity within the ERattenuated induction of the inflammatory cytokine response by
the holotoxins, as measured by transcription of IL-8 and nuclear
translocation of p65 (Figures 4A and 4B). There was no effect of
4m8C on the IL-8 response by the TLR4 pathway (Figure 4A, last
columns bLPS). We also found that transfection of IRE1a/
MEFs with wild-type IRE1a rescued the cytokine response, but
transfection with an IRE1a point mutant lacking endonuclease
activity (IRE1 a-K907A) did not (Figure 4C); except for a small
response to wild-type (WT) toxin that also induces cAMP.
Thus, activation of NF-kB in cells exposed to CT requires the
RNase activity of IRE1a but proceeds independently of XBP1
splicing.
This result implicates RIDD and degraded mRNA, or loss of
gene expression, in signal transduction between IRE1a and
NF-kB. IRE1 and the related endonuclease RNase L have
similar catalytic mechanisms and generate mRNA fragments
with 50-OH and cyclic 20,30 phosphodiester 30 ends (Dong
et al., 2001; Gonzalez et al., 1999). RNase L mRNA degradation
products have been observed to activate the RNA helicase
RIG-I, which senses single- and double-stranded uncapped
RNA and contributes to innate immunity against invading
viruses (Malathi et al., 2007; Malathi et al., 2010), in part by acti-
vating NF-kB (Kawai and Akira, 2008). To test whether mRNA
products of IRE1a might function in a similar signaling pathway,
we first used a well-characterized RIG-I deficient human hepa-
tocyte cell line, Huh 7.5, and its wild-type parent cell line (Huh
7.0). Huh 7.5 cells lacking a functional RIG-I were resistant to
induction of the inflammatory cytokine IL-8 by intoxication
with CT and its enzymatically inactive mutants, while Huh 7.0
cells were responsive (Figure 4D). Treatment with thapsigargin
(which also acts as a potent intracellular [Ca2+] agonist) induced
equal expression of IL-8 in both WT and RIG-I-deficient Huh cell
lines, showing that the NF-kB inflammatory pathways were
intact. Thus, in Huh cells, signal transduction induced by CT
between IRE1a and the cytokine genes appeared to be RIG-I
dependent.
To determine whether the 50-OH 30,20-cyclic phosphate mRNA
fragments generated by IRE1a (Gonzalez et al., 1999) can act in
this pathway to activate cytokine gene expression, we isolated
mRNA from IRE1a knockout mouse cells and subjected it to
cleavage in vitro with the truncated cytosolic kinase and RNaseCell Host & Microbe 13, 558–domain of human IRE1a expressed in and
purified from insect cells. As a control, we
performed the cleavage reaction in thepresence of 4m8C (Figure 4E). The low-molecular-weight RNA
fragments thus produced, including cleavage products of ribo-
somal RNA (as reported for IRE1a cytosolic domains [Iwawaki
et al., 2001]), were isolated by size fractionation, transfected
into Huh 7.0 or 7.5 cells, and assessed for their ability to promote
IL-8 mRNA expression. IL-8 levels increased in Huh 7.0 cells
transfected with RNA fragments produced by digestion with
IRE1a (Figure 4F). There was no IL-8 response in cells trans-
fected with the low-molecular-weight RNA fraction of the diges-
tion performed in the presence of 4m8C or after mock digestion,
indicating specificity for RNA fragments produced by IRE1a. Huh
7.5 cells that lack RIG-I did not respond to the transfected RNA
but retained their ability to induce IL-8 mRNA in response to
TNFa (Figure 4F). Thus, RNA fragments produced by IRE1a
RIDD activity in vitro can mediate the induction of the cytokine
genes by activation of RIG-I.
To confirm these results, we studied MEFs prepared from
mice lacking RIG-I or the mitochondrial antiviral signaling pro-
tein (MAVS) that is required for signal transduction by RIG-I.
We found that MEFs lacking RIG-I were resistant to induction
of IL-6 mRNA by intoxication with CT and its enzymatically
inactive mutants but retained their ability to induce IL-6 in
response to TNFa (Figure 4G). The RIG-I/ cells were also
strongly resistant to the nonspecific RIG-I agonist poly(I:C) as
expected, but we saw no evidence for activation of the RIG-I
analog MDA5 using this preparation of poly(I:C) (Kato et al.,
2008). Like the RIG-I/ cells, MEFs lacking MAVS (MAVS/)
were resistant to induction of IL-6 by intoxication with the
holotoxins. This was rescued (>10-fold) by stable transfection
with wild-type MAVS (WT MAVS rescue) (Figure 4H). MEFs
lacking the other RNA helicase MDA5 (MDA5/), however,
were responsive to intoxication with the holotoxins, indicating
specificity for RIG-1 in sensing mRNA fragments produced by
RIDD (Figure S4A). Thus, RIG-I and MAVS are required, but
MDA5 is not.
We do note, however, that each of the holotoxins induced a
small but detectable IL-6 response in MAVS/ cells, above
that of the CT B subunit alone, suggesting that RIG-I may not
be the only sensor for RIDD or that the toxins may induce other
inflammatory pathways in this cell line. We also note that RIDD
activation of RIG-I induces nuclear translocation of the569, May 15, 2013 ª2013 Elsevier Inc. 561
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Figure 3. The CT A Subunit Activates the IRE1a Pathway, but XBP1 and PERK Are Dispensable
(A–C) T84 cells were intoxicated as indicated and analyzed for phospho-IRE1a (A), the spliced form of XBP1 mRNA (B), and ERdj4 mRNA (C). T84 cells treated
with thapsigargin or apically applied LPS (aLPS) (or buffer alone) provided positive and negative controls, respectively.
(D–F) IRE1a or XBP1 was silenced in HeLa cells (D0 and E0). HeLa cells lacking IRE1a or XBP1 were intoxicated and analyzed for IL-6 mRNA expression by
real-time PCR (D and E) and nuclear translocation of p65 by immunoblot (F). TBP and b-actin are loading controls.
(G–I) MEF cells lacking IRE1a (IRE1a/; G), XBP1 (XBP1/; H), or PERK (PERK/; I) were intoxicated and analyzed for IL-6mRNA expression by real-time PCR.
Data are shown as means ± SEM. Nomenclature is as described in Figure 1. In (E0), * indicates nonspecific protein bands. See also Figure S3.
Cell Host & Microbe
IRE1a Operates in Innate Immunity within the ER
562 Cell Host & Microbe 13, 558–569, May 15, 2013 ª2013 Elsevier Inc.
Cell Host & Microbe
IRE1a Operates in Innate Immunity within the ERinterferon transcription factor IRF3 (Figure 4I) and a small but
IRE1a-dependent expression of interferon beta (IFNb, Table 1
and Figures S4B–S4D) as would be expected for signal trans-
duction by RIG-I.
To test whether our observations with CTmay define a general
rule for innate immune surveillance by the ER, we used the
closely related AB5 subunit Shiga toxin and SV40 virus. Like
CT, both Shiga toxin and SV40 virus must enter the ER to induce
disease. Here, we found that in MEFs expressing IRE1a, the
enzymatically inactive mutant of Shiga toxin induced an IL-6
response, but the B subunit alone did not, and this was
completely absent in MEF IRE1a/ knockout cells (Figure 5A).
We also found that infection by SV40 virus in intestinal T84
and Caco-2 cells induced a strong IL-8 response that was
inhibited by treatment with 4m8C (Figure 5B). These results
implicate signal transduction by RIDD and RIG-I. Thus, another
bacterial toxin and a pathogenic virus entering the ER of host
cells induce inflammation in the same way as CT. In contrast,
enzymatically inactivated Diphtheria/Anthrax chimera toxins
did not induce expression of the inflammatory cytokines after
intoxicating intestinal T84 or Caco-2 cells (Figure 5C). Unlike
CT, Shiga toxin, and SV40 virus, the chimera toxins enter the
cytosol by translocating across endosome membranes. They
do not traffic to the ER.
We also tested for the IRE1a-RIDD pathway in cells of hemato-
poietic lineages operating classically in innate immunity. Here,
we found that macrophages isolated from WT mice responded
to the CT A subunit by expression of inflammatory cytokines
and this was dependent on RIDD as evidenced by inhibition
with 4m8C (Figure 5D). But macrophages isolated from mice
lacking MAVs did not. These results in macrophages fully reca-
pitulate our findings in epithelial cells and fibroblasts, further
implicating a general rule for innate immune surveillance
by IRE1a.
Activation of IRE1a by Toxin Binding
How does the CT A subunit activate IRE1a? Recent evidence
suggests that in the UPR, the yeast homolog of IRE1a is acti-
vated by direct binding to unfolded proteins in the ER lumen
(Gardner and Walter, 2011). Accordingly, the CT A subunit,
which is unfolded in the ER prior to retrotranslocation, could spe-
cifically activate IRE1a by directly binding to the lumenal domain
of IRE1a. To test this hypothesis, we probed an array of peptide
sequences derived from tiling along the sequence of the CT A
subunit for binding to the purified mouse Ire1a ER-lumenal
domain (mIre1a-LD). The signal intensity attributed to each
amino acid for binding Ire1a was averaged and normalized to a
scale of 0–1 as described previously (Gardner and Walter,
2011). Two regions within the CT A subunit showed prominent
binding to mIre1a-LD (Figures 6A and 6B). Both sites are located
within the A1 chain (Figures 6A–6C), which is the fragment of the
A subunit retrotranslocated to the cytosol (Tsai et al., 2001; Wer-
nick et al., 2010). GST alone did not bind the array (data not
shown), and the pattern of binding to the core lumenal domain
of mouse PERK (mPERK-LD) was different. mPERK-LD bound
prominently to one region in the A2 chain (uniquely to PERK)
and one region in the A1 chain that partially overlapped with
one of the IRE1a binding sites (K. Gotthardt and P.W., unpub-
lished data).Cell HWe tested for direct protein-protein interaction by coimmuno-
precipitation of the A1 chain with FLAG-tagged IRE1a stably
transfected in HeLa cells. In cells treated with WT CT, the anti-
FLAG antibodies immunoprecipitated IRE1a and the CT A1
chain (Figure 6D). This was blocked in cells treated with BFA
that inhibits entry of the toxin into the ER. There was no detect-
able A1 chain signal in control HeLa cells lacking FLAG-tagged
IRE1a orwhen the cells were not intoxicated. These results impli-
cate a mechanism for IRE1a activation by direct binding to the
unfolded CT A1 chain.
DISCUSSION
Our findings delineate a mechanism of innate immunity uniquely
localized to the lumenal ER membrane. In response to the pres-
ence of a bacterial protein that is unfolded in the ER, IRE1a is
activated to generate endogenous RNA ligands that engage an
innate immune effector mechanism previously believed to be
dedicated to antiviral defense (see the graphical abstract).
RNase L, whose effector domain evolved from IRE1a by gene
duplication (Bork and Sander, 1993), performs a similar task by
generating RIG-I ligands to amplify signaling in virally infected
cells. RIDD is absent from budding yeast and is first reported
in animal cells (Hollien and Weissman, 2006). It seems likely,
therefore, that IRE1’s endonuclease activity is the ancestral
function, duplicated and extended in RNase L, and utilized in
animal cells for antibacterial and antiviral defense.
IRE1a, the most evolutionarily ancient regulator of the UPR, is
selectively activated by the ER-localized CT A subunit; neither
PERK nor ATF6 are detectably activated. Based on our results,
we consider it likely that IRE1a binds specific sites in the
unfolded A1 chain to cause activation of RIDD. The core lumenal
domain of PERK also binds regions of the A subunit, but in a
different pattern, binding a single predominant region in the A1
chain and a second site in the A2 chain, a region of the A subunit
that does not engage ERAD and is not retrotranslocated to the
cytosol. As we find no evidence that PERK is activated in vivo,
this interaction may either not occur in living cells, perhaps due
to steric accessibility of that portion of the A1 chain in the ER
lumen, or, if it did occur, would not lead to productive PERK
activation.
With two binding sites, it is possible that the A1 chain binds
IRE1a with high avidity, perhaps even tethering adjacent IRE1
dimers to form higher oligomers. This might explain how CT
rapidly activates only one arm of the ER stress modules. High-
avidity binding might also account for how the small amounts
of toxin entering the ER lumen of host cells can cause RIDD. It
could also be that ER chaperones are required to facilitate bind-
ing of the A1 chain to IRE1a, imparting specificity to the binding
reaction and activation of signal transduction by coincident
detection.
Mechanisms of innate immunity emanating from the ER have
not been previously recognized. Two recent reports show that
signal transduction induced by TLRs can be affected by the ER
stress response (Martinon et al., 2010), and conversely that the
ER stress response accommodates cell survival in TLR-depen-
dent innate immunity (Richardson et al., 2010). Neither paper,
however, addresses the idea, or explains how the ER can act
in sensing invasion of extracellular microbes and their products.ost & Microbe 13, 558–569, May 15, 2013 ª2013 Elsevier Inc. 563
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Figure 4. The Inflammatory Response Depends on the RNase Activity of IRE1a and on RIG-I, a Cytosolic Sensor of RNA Fragments
(A and B) T84 cells pretreated with 5 mM 4m8C for 5 min were intoxicated and analyzed for transcription of IL-8 (A) and nuclear translocation of p65 (B). TBP is a
loading control.
(C) Wild-type IRE1a rescued and K907A RNase domain-dead transfected IRE1a knockout MEFs were intoxicated and analyzed for transcription of IL-6.
(D) Huh 7.0 (WT) and Huh 7.5 (mutant RIG-I) cells were intoxicated and IL-8 mRNA was measured.
(E) Purified RNA from IRE1 knockout cells was digested with purified cytosolic domain of human IRE1a in the presence or absence of 4m8C.
(F) Low-molecular-weight fragments of mRNA produced in vitro were transfected in Huh 7.0 (WT) and Huh 7.5 (mutant RIG-I) cells for 16 hr and IL-8 mRNA was
assessed.
(G) Wild-type primary MEFs (RIG-I+/+) or immortalized MEFs lacking RIG-I (RIG-I/) were intoxicated, and IL-6 mRNA was measured.
(legend continued on next page)
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Figure 5. The IRE1-RIDD Pathway Defines a
General Rule for Innate Immune Surveil-
lance by the ER
(A) Wild-type MEFs or MEFs lacking IRE1a
(IRE1a/) or RIG-I (RIG-I/) were intoxicated
with an enzymatically inactive Shiga toxin mutant
(StxE) or its B subunit alone (STxB), and IL-6
mRNA was quantified.
(B and C) T84 or Caco-2 cells pretreated or not
with 4m8C were infected with SV40 virus (B) or
Anthrax-fused Diphtheria (C) for 4h and immune
responses were assessed by qPCR.
(D) Wild-type macrophages or MAVS knockout
macrophages pretreated or not with 4m8C were
intoxicated with toxins for 4 hr and analyzed for
IL-6 by qPCR.
Data are shown as means ± SEM. PA, protective
antigen; LFN, amino-terminal 255 residues of lethal
factor; LFNDTA*, fusion protein composed of LFN
and the inactive catalytic domain of diphtheria
toxin; LFNDTA, fusion protein composed of LFN
and the catalytic domain of diphtheria toxin. Other
nomenclature is as in Figures 1 and 4.
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IRE1a Operates in Innate Immunity within the ERThe reaction we describe is also distinct from the recently
described pathway for induction of inflammation by the related
E. coli AB5 subunit subtilase toxin. Subtilase toxin enters the
ER of host cells like CT, but then causes severe damage by enzy-
matic degradation of BiP to induce massive ER stress. In
contrast, IRE1a senses entry of CT into the ER in the absence
of cell damage. Neither the process of retrotranslocation nor(H) MEF cells lacking the scaffolding protein MAVS (MAVS/) and the same cells rescued by transfect
intoxicated, and IL-6 mRNA was measured.
(I) Caco-2 and HeLa cells were intoxicated and analyzed for nuclear translocation of IRF3 by immunoblot. T
Poly(I:C) and TNFa were used as positive controls. Data are shown as means ± SEM. Nomenclature is as in
Cell Host & Microbe 13, 558–the canonical UPR appear to be involved,
suggesting a form of pattern recognition.
It is not readily apparent, however, how
the unfolded A1 chain fits the classic defi-
nition of a PAMP. The motifs on the A1
chain implicated in binding IRE1a are
located on the surface of the molecule
when in its folded conformation (Fig-
ure 6C), and like other well-established
PAMPs (DNA or RNA), the peptide
sequences when taken out of context
are not uniquely microbial. We presume
that specific binding to the MHC-class-I-
like groove of IRE1a (Credle et al., 2005)
can only occur when the A1 chain is
unfolded. The CT B subunit enters the
ER along with the A1 chain, but the B sub-
unit is not unfolded and does not bind or
activate IRE1a to activate RIDD. Small
amounts of unfolded proteins, however,
are present in the ER at all times. Perhaps
the signature feature of the CT A1 chain is
regions of the protein that allow unfoldingupon entry into the ER and then refolding upon retrotranslocation
to the cytosol, the opposite pattern for protein folding in the
biogenesis and quality control of endogenous proteins. This is
a feature fundamentally required of the bacterial and viral pro-
teins that co-opt the ER for causation of disease. Other factors
may be that the A1 chain acts only on the IRE1a branch of the
ER stress sensors.ion with wild-type MAVS (wt MAVS rescue) were
BP is a loading control.
Figure 1. See also Figure S4.
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Figure 6. The Luminal Domain of Mouse IRE1a Binds Two Motifs in
the CT A1 Chain
(A) An array of 18-mer peptides derived from the CT A subunit was incubated
with purifiedmIre1a tagged with GST, and binding was detectedwith anti-GST
antibodies.
(B) The contribution of each amino acid to binding mIre1a was plotted along
the sequence of the CT A subunit from the N to C terminus, revealing two
distinct GST-mIre1a binding sites.
(C) The cholera toxin crystal structure. Themotifs that appear to bind IRE1a are
on the external surface of the A1 chain (residues highlighted in yellow and
orange).
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RIG-I are also interesting in light of the known properties of
RIG-I in initiating interferon (IFN) responses against invading
viruses. We observe a small IRE1a-dependent IFN response
in the studies described here, and stronger cytokine response
initiated by NF-kB. Thus, the RIG-I/MAVS complex may differ-
entially effect each signaling cascade as suggested before
(Poeck et al., 2010), perhaps by discerning the activating ligand
structures or the ligand concentrations. The activating ligands
for natural RLR signal transduction are not yet fully defined
with clarity (Loo and Gale, 2011; Rehwinkel and Reis e Sousa,
2010). In contrast, the cleavage products of IRE1 endonuclease
activity (RIDD) are well delineated—they are single-stranded
mRNA fragments with 50-OH and a 20,30-cyclic phosphate
terminus (Gonzalez et al., 1999). Our results implicate these
fragments as activating ligands for RIG-I. The same 50-OH
and 20,30-cyclic phosphate mRNA fragments produced by
RNase-L after viral infection also activate RIG-I (Malathi et al.,
2007).
Mammals have a second isoform of IRE1 (IRE1b) whose
expression is restricted to the heavily microbial colonized epithe-
lium of the gut and whose absence predisposes to colitis (Berto-
lotti et al., 2001). We hypothesize the CT A1 chain also interacts
with the lumenal domain of IRE1b, possibly with greater affinity,
allowing for an augmented response. IRE1b’s restricted expres-
sion and the finding that its RIDD activity is enhanced compared
to its sequence-specific XBP1 splicing activity (Imagawa et al.,
2008) suggest that mammals may broadly utilize RIDD-depen-
dent immune surveillance, with strong amplification in the intes-
tine that constitutes the essential interface between the host and
hundreds of trillions of gut microbes.
EXPERIMENTAL PROCEDURES
Plasmids, purification, and other reagents used, as well as detailed experi-
mental procedures can be found in the Supplemental Experimental
Procedures.
Cell Culture
Human intestinal epithelial T84 cells (ATCC) were cultured as previously
described (Lencer et al., 1992). Cells were incubated with 3 nM WT or mutant
CT apically and 300 ng/ml LPS apically as negative or basolaterally as positive
control, or 3 mM thapsigargin and 10 ng/ml recombinant human TNFa apically
and basolaterally at various time points. Where indicated, intestinal T84 cells
were pretreated with 5 mM brefeldin A or with 25 mMBay 11 for 30 min. Human
cervical epithelial HeLa cells transfected with shRNA against IRE1a or XBP1
were cultured in Dulbecco’s modified Eagle’s medium (DMEM) supplemented
with 10% fetal bovine serum (FBS) and 2 mg/ml puromycin. HeLa cells were
preloaded with 4 mM GM1 purified from bovine brain (a generous gift from
David Ullman, VA Hospital, Bedford, MA) for 45–90min at 37Cbefore addition
of toxins. Human hepatocyte Huh 7.0 and 7.5 and MEFs from wild-type and
mutant mice (IRE1a knockout, XBP1 knockout, PERK knockout, RIG-I
knockout, and MAVS knockout) were previously described (Lindenbach
et al., 2005; Lee et al., 2003; Sun et al., 2006; Urano et al., 2000). HEK293T
and Huh cells and MEFs were maintained in DMEM supplemented with
10% FBS.(D) HeLa cells expressing FLAG-tagged IRE1a were intoxicated with WT CT in
the presence or absence of BFA. IRE1awas immunoprecipitated and analyzed
by immunoblot with antibodies against the CT A and B subunits (upper panel)
and FLAG (middle panel). Total cell lysates were also immunoblotted for the A1
chain to provide additional controls (lower panel).
nc.
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Total cellular RNA from IRE1a/b-deleted cells was collected and harvested by
solvent extraction with RNAstat60, according to the manufacturer’s instruc-
tions (AMSbio). RNA (250 mg) was incubated with or without 2 mM human
IRE1a [464–977] purified from insect cells, as described previously (Cross
et al., 2012), in the presence or absence of 64 mM 4m8C for 1 hr at 30C.
Low-molecular-weight RNA fragments (<200 nt) were isolated by mirVana
glass fiber filtration, according to the manufacturer’s instructions (Invitrogen).
IRE1a-mediated RNA digestion was confirmed by microfluidic capillary elec-
trophoresis with a Bioanalyzer (Agilent).
Peptide Arrays
A peptide array of 18-mers tiling through the cholera toxin A subunit by 3 aa at
a time was purchased from theMIT Biopolymers Laboratory (Cambridge, MA).
The array was incubated in methanol for 10 min and then in binding buffer
(50 mM Tris [pH 7], 150 mM NaCl, 10% glycerol, 2 mM DTT, and 0.02%
Tween-20) for three 10 min washes. After 1 hr incubation at room temperature
with 1 mMGST-mIre1a, the array was washed three times for 10 min in binding
buffer to remove unbound protein. Using a semidry transfer apparatus, bound
GST-mIre1a was transferred to a nitrocellulose membrane and detected with
a-GST tag antibody (Abcam). Intensities were quantified with ImageQuant
Array analysis software with background subtraction for a spot containing
no peptide. For calculation of the contribution of each amino acid to GST-
mIre1a binding, the intensity of each spot containing a particular 3 aa tile
was averaged. Average spot intensities were normalized to the maximum
spot intensity for each array.
Quantitative Real-Time qPCR
Total RNA of cells was extracted with the RNeasy mini kit (QIAGEN). Comple-
mentary DNA was prepared from total RNA with the Superscript first-strand
synthesis system (Invitrogen) with the oligo (dT)12-18 primers, according to
the manufacturer’s instructions. RNA samples were treated with DNase I (Invi-
trogen) for the elimination of genomic DNA. Cytokine mRNA expression was
determined by real-time qPCR with relative quantitation by the comparative
threshold cycle number (Ct) method, iCycler, and SYBR Green Ready-mix
(Bio-Rad) and normalized by housekeeping gene (b-actin or GAPDH).
Preliminary experiments were performed with each primer pair to determine
the amplification temperature that provided an optimal correlation between
template concentration and signal intensity. At least three independent exper-
iments were performed for each assay.
Intestinal Epithelial Cell Isolation from Mice
BALB/c mice (littermates, 6–8 weeks old) were obtained from The Jackson
Laboratory. All procedures were approved by the Boston Children’s Hospital
Institutional Animal Care and Use Committee. Mice were treated with 50 mg
toxin in PBS by intragastric feeding following a 3 hr starvation. The mice
were sacrificed, and the small intestine was immediately taken out and flushed
with ice-cold PBS. The proximal small intestine was cut into 3 cm pieces, and
Peyer’s Patches were removed. For multiplexed mRNA detection, 0.5 mg
whole tissue (stored in RNAlater solution from Ambion) was homogenized
in RLT buffer (QIAGEN) supplemented with b-mercaptoethanol using the
gentleMACS Dissociator (Miltenyi Biotech). Nanostring nCounter analysis
was performed by the Harvard Digestive Diseases Center Epithelial Cell
Biology Core. For isolation of intestinal epithelial cells (IECs), pieces of the
intestine were washed three times in ice-cold PBS and were incubated with
1 mM DTT in HBSS for 10 min in order to remove mucus in the lumen. After
three washes with ice-cold PBS, pieces were incubated in 1 U/ml Dispase
(Roche) in RPMI media for 30 min at 37C. The isolated epithelial cells were
collected by filtration through a 100 mm cell strainer (BD Bioscience) and
centrifugation for 5 min at 1,500 rpm at 4C. The cells were resuspended in
5 ml 100% Percoll (GE Healthcare), followed by layering with 8 ml 40% Percoll
in RPMI. Cells were centrifuged for 20 min at 1,500 rpm without braking, and
IECs were collected from the top 30% and washed with RPMI for the RNA
extraction as described above.
Nanostring Analysis with nCounter
The NanoString nCounter gene expression system (NanoString Technolo-
gies) was used to quantify individual mRNA transcripts. In brief, RNA wasCell Hextracted from polarized T84 cells, mouse IECs, or mouse whole-tissue
preparation previously homogenized in RLT buffer. For hybridization, RNA
or homogenate was incubated for 16 hr with the Codeset and loaded into
the nCounter prep station, followed by quantification with the nCounter
Digital Analyzer. So that side-by-side comparisons of nCounter experiments
could be made, the nCounter data were normalized in two steps. The
positive spiked-in controls provided by the nCounter instrument were used
as per the manufacturer’s instructions, and the copy numbers were normal-
ized by five housekeeping genes (b-actin, B2M, GAPDH, HPRT1, and
RP13A).
Immunoblot Analyses
Cells were lysed with RIPA lysis buffer (20 mM Tris [pH 7.5], 150 mMNaCl, 1%
NP-40, 0.1%SDS, and 0.5% sodiumdeoxycholate) supplementedwith EDTA-
free protease inhibitor cocktail tablet or phosphatase inhibitor cocktail tablet
(Roche) by incubation on ice for 1 hr. The total lysate was then clarified by
centrifugation at 14,000 rpm for 20 min at 4C. The supernatants were
collected, and protein concentration was determined via the BCA procedure
as described by the manufacturer (Pierce). Equal amounts of protein
(15–30 mg total cell lysate) were mixed with reducing Laemmli SDS sample
buffer, boiled, and resolved by SDS-PAGE, followed by transfer to a nitrocel-
lulose membrane. Antigens were detected with the appropriate antibody
followed by enhanced chemiluminescence (ECL) according to the manufac-
turer’s instructions (Pierce).
Phos-Tag Gels
Phos-tag gels weremade in the sameway as the immunoblot described above
except (1) 6.5% SDS-PAGE containing 10 mM Phos-tag (NARD Institute) and
10 mM MnCl2 were used and (2) gels were soaked in 1 mM EDTA for 10 min
before transfer onto a polyvinylidene difluoride membrane.
Nuclear Extraction
T84 cells were harvested from 6-well plate inserts and washed twice with
PBS. Cells were resuspended in 80 ml cold hypotonic buffer (10 mM HEPES
[pH 7.9], 10 mM MgCl2, 10 mM KCl, and 0.5 mM DTT) supplemented with
EDTA-free protease inhibitor and incubated on ice for 15 min, followed by
addition of 25 ml 10% NP-40. The pellet was spun at 12,000 rpm for 30 s
at 4C and resuspended in 50 ml extraction buffer (20 mM HEPES [pH 7.9],
1.5 mM MgCl2, 400 mM NaCl, 25% glycerol, 0.2 mM EDTA, and 0.5 mM
DTT) supplemented with EDTA-free protease inhibitor. The supernatant
was collected by centrifugation for 5 min at 4C and loaded onto the SDS-
PAGE gel.
Coimmunoprecipitation
HeLa cells stably overexpressing FLAG-IRE1a were loaded with 4 mM GM1
and intoxicated with 40 nM WT CT for 90 min in the presence or absence of
a 10 mM BFA 30 min pretreatment. Cells were lysed with M-PER lysis buffer
(Pierce) supplemented with EDTA-free protease inhibitor cocktail tablet and
phosphatase inhibitor cocktail tablet by incubation on ice for 10 min. The total
lysate was then clarified by centrifugation at 14,000 rpm for 20 min at 4C. The
supernatants were collected and precleared with mouse IgG-agarose (Sigma).
The protein concentration was determined via the BCA procedure as
described by themanufacturer. Equal amounts of the protein lysate were incu-
bated with anti-FLAG-agarose beads (Sigma) overnight at 4C and washed
with washing buffer (25 mM Tris [pH. 7.2] and 0.15 M NaCl). The beads were
boiled in the absence of reducing reagent first to release the protein complex,
then 100 mM DTT was added and heated at 70C for 5 min. The supernatant
was resolved by SDS-PAGE followed by transfer to a nitrocellulose mem-
brane. Antigens were detected with the CTA antibody followed by enhanced
chemiluminescence (ECL).
Statistical Analysis
All data are representative of at least three independent experiments. Data are
shown as mean ± SEM unless otherwise indicated. Statistical significance of
comparison between two groups was determined by two-tailed Student’s
t test where indicated. For comparison of more than one group, one-way
ANOVA was used. Significant differences were considered at p values of
less than 0.05.ost & Microbe 13, 558–569, May 15, 2013 ª2013 Elsevier Inc. 567
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